As the wild-type strain, oZIKV_2k induced tumor remission in 83% (five of six) of treated animals and complete metastatic remission (tumors in the spinal cord) in 33% (two of six) of USP7 tumor-bearing mice (Figure 7B). This evidence concerns the gene USP7 and neoplasm.